Status:
RECRUITING
Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Institut Pasteur
Institut Pasteur de Madagascar
Conditions:
Malaria Vivax
Malaria Falciparum
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The resilience of P. vivax to malaria elimination efforts is due to its ability to form dormant liver stages (hypnozoites) that reactivate weeks to months after the initial infection causing recurrent...
Detailed Description
In each country, 24 clusters (48 clusters in total) will be randomly allocated using computer generated numbers to one of the two interventions: Arm 1 (PvSeroTAT intervention) or Arm 2 (Control arm)....
Eligibility Criteria
Inclusion
- Participant will remain in the study area for at least the next month.
- Participant is older than 12 months
Exclusion
- • Participant is unwilling to participate.
Key Trial Info
Start Date :
May 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 28 2027
Estimated Enrollment :
19200 Patients enrolled
Trial Details
Trial ID
NCT06923592
Start Date
May 12 2025
End Date
April 28 2027
Last Update
September 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Armauer Hansen Research Institute
Addis Ababa, Ethiopia
2
Institut Pasteur de Madagascar
Antananarivo, Madagascar